Jonathan Yang named director of clinical research at NYU Brain and Spine Tumor Center

NYU study details how cancer cells evade chemotherapy

Laboratory experiments with cancer cells reveal two ways in which tumors evade chemotherapy drugs designed to starve and kill them, a new study in Nature Metabolism shows.

December 06, 2024

Vol.50 No.45

In Brief

NYU pain research center receives $4.5M NIH grant to study chemotherapy-related pain

NIH has awarded a five-year, $4.63 million grant to NYU College of Dentistry researchers to study chemotherapy-induced painful peripheral neuropathy, or CIPPN.

October 11, 2024

Vol.50 No.38

In Brief

Jonathan Gerber named chief clinical officer of NYU Langone Health’s Perlmutter Cancer Center

Jonathan M. Gerber was named chief clinical officer of NYU Langone Health’s Perlmutter Cancer Center.

July 26, 2024

Vol.50 No.30

Clinical Roundup

AI tool helps to diagnose and predict severity of lung cancers

A computer program based on data from nearly a half-million tissue images and powered by artificial intelligence can accurately diagnose cases of adenocarcinoma, the most common form of lung cancer, a study published June 11 in Nature Communications shows.

June 14, 2024

Vol.50 No.24

In Brief

NYU Dentistry’s Pain Research Center receives $8M NIH grant to study oral cancer pain

Researchers at NYU Dentistry’s Pain Research Center have been awarded a five-year, $8 million NIH grant to study signaling mechanisms that generate oral cancer pain. The funding is part of the NIH’s Helping to End Addiction Long-term Initiative, which supports the development of safe and effective therapeutics to treat pain in an effort to end the opioid crisis.

April 12, 2024

Vol.50 No.15

In Brief

Alexandra Miller named chief of neuro-oncology and co-director of Brain and Spine Tumor Center at NYU Perlmutter

Alexandra Miller, a neurologist and neuro-oncologist specializing in treating primary brain tumors, has been named as the chief of the Division of Neuro-Oncology and co-director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, effective Jan. 29.

January 26, 2024

Vol.50 No.04

Jonathan Yang named director of clinical research at NYU Brain and Spine Tumor Center

YOU MAY BE INTERESTED IN

NYU study details how cancer cells evade chemotherapy

NYU pain research center receives $4.5M NIH grant to study chemotherapy-related pain

Jonathan Gerber named chief clinical officer of NYU Langone Health’s Perlmutter Cancer Center

AI tool helps to diagnose and predict severity of lung cancers

NYU Dentistry’s Pain Research Center receives $8M NIH grant to study oral cancer pain

Alexandra Miller named chief of neuro-oncology and co-director of Brain and Spine Tumor Center at NYU Perlmutter

Renew today!

Subscriber content

Never miss an issue!

Login